Cargando…

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder worldwide. Its main neuropathological hallmarks are the degeneration of dopaminergic neurons in the substantia nigra and alpha-synuclein containing protein inclusions, called Lewy Bodies. The diagnosis of idiopathic PD is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roser, Anna Elisa, Caldi Gomes, Lucas, Schünemann, Jonas, Maass, Fabian, Lingor, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135037/ https://www.ncbi.nlm.nih.gov/pubmed/30233304 http://dx.doi.org/10.3389/fnins.2018.00625

Ejemplares similares

MicroRNAs from extracellular vesicles as a signature for Parkinson's disease
por: Caldi Gomes, Lucas, et al.
Publicado: (2021)

miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons
por: Roser, Anna-Elisa, et al.
Publicado: (2018)

The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
por: Joppe, Karina, et al.
Publicado: (2019)

Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases
por: Wang, Lin, et al.
Publicado: (2020)

Circulating miRNAs, Small but Promising Biomarkers for Autism Spectrum Disorder
por: Salloum-Asfar, Salam, et al.
Publicado: (2019)

Circulating miRNAs as diagnostic biomarkers for adolescent idiopathic scoliosis
por: García-Giménez, José Luis, et al.
Publicado: (2018)

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
por: Yang, Yimin, et al.
Publicado: (2021)

Multi‐omic landscaping of human midbrains identifies disease‐relevant molecular targets and pathways in advanced‐stage Parkinson's disease
por: Caldi Gomes, Lucas, et al.
Publicado: (2022)

Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
por: Lin, Jen-Tai, et al.
Publicado: (2021)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
por: Roser, Anna-Elisa, et al.
Publicado: (2017)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
por: Oliveira, Sara R., et al.
Publicado: (2020)

Methodological challenges in utilizing miRNAs as circulating biomarkers
por: Moldovan, Leni, et al.
Publicado: (2014)

Challenges in Using Circulating miRNAs as Cancer Biomarkers
por: Tiberio, Paola, et al.
Publicado: (2015)

A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker
por: Ma, Chenkai, et al.
Publicado: (2018)

Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
por: Li, Jia, et al.
Publicado: (2020)

Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities
por: Felekkis, Kyriacos, et al.
Publicado: (2023)

Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia
por: Dong, Xiaoyu, et al.
Publicado: (2020)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
por: Alves dos Santos, Katiusse, et al.
Publicado: (2020)

Circulating Exosomal miRNAs as Novel Biomarkers Perform Superior Diagnostic Efficiency Compared With Plasma miRNAs for Large-Artery Atherosclerosis Stroke
por: Niu, Mengying, et al.
Publicado: (2021)

miRNA in Circulating Microvesicles as Biomarkers for Age-Related Cognitive Decline
por: Rani, Asha, et al.
Publicado: (2017)

Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples
por: Chen, Lei, et al.
Publicado: (2018)

Dysregulation of Principal Circulating miRNAs in Non-human Primates Following Ischemic Stroke
por: Chen, Jian, et al.
Publicado: (2021)

Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis
por: Cheng, Yang-Fan, et al.
Publicado: (2023)

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)

The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis
por: Zhang, Xiaoyi, et al.
Publicado: (2018)

Diagnostic significance of circulating miRNAs in systemic lupus erythematosus
por: Zheng, Xiaolan, et al.
Publicado: (2019)

Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
por: Panio, A., et al.
Publicado: (2022)

Potential diagnostic role of circulating MiRNAs in colorectal cancer
por: Abo-elela, Dina A, et al.
Publicado: (2023)

Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease
por: Wang, Lin, et al.
Publicado: (2020)

Circulating miRNAs can serve as potential diagnostic biomarkers in chronic myelogenous leukemia patients
por: Keramati, Farid, et al.
Publicado: (2021)

miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma
por: Jiang, Li, et al.
Publicado: (2021)

Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
por: Mencias, Mark, et al.
Publicado: (2021)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers for Celiac Disease Development
por: Tan, Ineke L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qdu5gm4idr0370uh407li9giqk